Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OPIPRAMOL for Pulmonary embolism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where OPIPRAMOL was used for Pulmonary embolism.

Most Reported Side Effects for OPIPRAMOL

Side Effect Reports % Deaths Hosp.
Fall 62 17.4% 0 61
Dizziness 57 16.0% 0 43
General physical health deterioration 39 10.9% 3 39
Fatigue 36 10.1% 0 17
Foetal exposure during pregnancy 36 10.1% 0 3
Toxicity to various agents 29 8.1% 8 3
Abnormal palmar/plantar creases 27 7.6% 0 1
Diarrhoea 26 7.3% 0 13
Dysmorphism 26 7.3% 0 1
Suicide attempt 26 7.3% 1 10
Confusional state 23 6.4% 2 23
Delirium 22 6.2% 0 17
Neonatal respiratory distress syndrome 22 6.2% 0 5
Product prescribing error 22 6.2% 0 22
Selective eating disorder 22 6.2% 0 1

Other Indications for OPIPRAMOL

Product used for unknown indication (197) Depression (37) Anxiety disorder (17) Schizophrenia (12) Foetal exposure during pregnancy (6)

Other Drugs Used for Pulmonary embolism

RIVAROXABAN (11,707) APIXABAN (5,234) WARFARIN (1,552) ENOXAPARIN (1,155) HEPARIN (786) ALTEPLASE (617) DABIGATRAN ETEXILATE (527) DALTEPARIN (431) EDOXABAN (307) XARELTO (284)

Related Pages

OPIPRAMOL Full Profile All Pulmonary embolism Drugs OPIPRAMOL Demographics OPIPRAMOL Timeline